Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 61

Sort by

Sort Order Select

Journal Articles

Sub-Cutaneous Rituximab-Minichop Versus Sub-Cutaneous Rituximab-Minichop + Lenalidomide (R2-miniCHOP) in Diffuse Large B Cell Lymphoma for Patients of 80 Years Old or More (SENIOR Study). a Multicentric Randomized Phase III Study of the Lysa

Lucie Oberic, MD, Mathieu Puyade, MD, Frederic Peyrade, MD, Herve Maisonneuve, MD, Julie Abraham, Pierre Feugier, MD, Catherine Thieblemont, MD PhD, Gilles Salles, MD PhD, Fontanet Bijou, MD, Gian-Matteo Pica, MD, Philippe Ruminy, PhD, Peggy Dartigues-Cuillères, MD, Gandhi Damaj, MD PhD, Philippe Gaulard, MD PhD, Jean-François Emile, MD PhD, Bettina Fabiani, Herve Tilly, MD PhD, Corinne Haioun, MD PhD, Fabrice Jardin

Blood (2019) 134 (Supplement_1): 352.

https://doi.org/10.1182/blood-2019-123612

Published: 2019

Journal Articles

The Incidence of Heparin Induced Thrombocytopenia before and after the Implementation of the Venous Thromboembolism Thromboprophylaxis Protocols within Eastern Health

Kristina Roche, Brian Harnett, MD, Leona Browne, Stephanie Young, PharmD, Rufaro S. Chitsike, MD

Blood (2019) 134 (Supplement_1): 2447.

https://doi.org/10.1182/blood-2019-129340

Published: 2019

Journal Articles

Prevalence of Venous Thromboembolism in Ambulatory and Non-Ambulatory Patients with Cerebral Palsy

Michael Daunov, DO, Justin Rondinelli, MD, Sanjay P Ahuja, MD, Nathan Richard Stehouwer, MD

Blood (2019) 134 (Supplement_1): 2428.

https://doi.org/10.1182/blood-2019-130622

Published: 2019

Journal Articles

Hypofibrinogenemia in Patient with Extended Exposure to Argatroban Therapy

Mustafa Saudi, MD

Blood (2018) 132 (Supplement 1): 5035.

https://doi.org/10.1182/blood-2018-99-117765

Published: 2018

Journal Articles

Risk Factors and Outcomes of Deep Vein Thrombosis in Pediatric Osteomyelitis

Maria Ahmad, MBBS, Christine M. Knoll, MD, Sanjay J. Shah, MBBS, Lucia Mirea, PhD

Blood (2018) 132 (Supplement 1): 5054.

https://doi.org/10.1182/blood-2018-99-111411

Published: 2018

Journal Articles

Real World Outcomes with VTD and Cybord Induction Treatment for Transplant Eligible Multiple Myeloma Patients in a Latin American Country. Retrospective Cohort Study from Gamm (Grupo Argentino de Mieloma Multiple)

Natalia Paola Schutz, MD MSc, Paola Ochoa, MD, Patricio Duarte, MD, Guillermina Remaggi, MD, Sebastian Yantorno, MD, Ariel Corzo, MD, Soledad Zabaljauregui, MD, Claudia Shanley, MD, Sergio Lopresti, MD, Sergio Orlando, MD, Veronica Verri, MD, Luis Dario Quiroga, MD, Carlos García, MD, Vanesa Fernandez, MD, Dorotea Beatriz Fantl, MD

Blood (2018) 132 (Supplement 1): 3301.

https://doi.org/10.1182/blood-2018-99-116243

Published: 2018

Journal Articles

Comparative Use of Direct Oral Anticoagulants and Warfarin in the Treatment of Atrial Fibrillation and Venous Thromboembolism and Prophylaxis: A Retrospective Single Center Utilization Study

Linda Hoang, MD, Josephine Pineda Dela Cruz, MD, Stephen Farley, PharmD, Julia Sessa, PharmD, Jamie Chin, PharmD, Rose Calixte, PhD, Alexander Hindenburg, MD

Blood (2017) 130 (Supplement 1): 3367.

https://doi.org/10.1182/blood.V130.Suppl_1.3367.3367

Published: 2017

Journal Articles

Incidence of Bleeding Events in Acute Myeloid Leukemia (AML) Patients Receiving Anticoagulation Therapy for Treatment of Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE) Who Are Also Undergoing Induction or Re-Induction Therapy

Meagan Scott, PharmD, Maho Hibino, PharmD, Marie Cavalier, PharmD, Bayard L. Powell, MD, Dianna S. Howard, MD, Leslie Renee Ellis, MD, Rupali Bhave, MD, Susan Lyerly, P.A.-C., Megan Manuel, M.S.N, Sarah Dralle, M.S.N., Timothy S Pardee, MD PhD

Blood (2017) 130 (Supplement 1): 2091.

https://doi.org/10.1182/blood.V130.Suppl_1.2091.2091

Published: 2017

Journal Articles

Response-Adapted Therapy for Newly Diagnosed Myeloma

Frederic J. Reu, MD, Tomas Radivoyevitch, PhD, Jason Valent, MD, Chad Cummings, MBA, Katherine Tullio, MPH, MS, Debbie Hastings, Beth M Faiman, PhD RN, MSN, CNP, AOCN, Kimberly Hamilton, CNP, Janice Reed, RN, Mary Ann Karam, RN, Matt Kalaycio, MD FACP, Hien K. Liu, MD, Christy Samaras, DO, Brian J. Bolwell, MD, Mitchell R. Smith

Blood (2016) 128 (22): 3606.

https://doi.org/10.1182/blood.V128.22.3606.3606

Published: 2016

Journal Articles

Heparin-Induced Thrombocytopenia Antibody Testing and Its Cost Effectiveness: Taking a Financial HIT

Anusiyanthan Isaac Mariampillai, MD, Josephine Pineda Dela Cruz, MD, Harry Staszewski, MD, Nina D'Abreo, MD

Blood (2016) 128 (22): 2343.

https://doi.org/10.1182/blood.V128.22.2343.2343

Published: 2016

Journal Articles

Pembrolizumab in Combination with Pomalidomide and Dexamethasone (PEMBRO/POM/DEX) for Pomalidomide Exposed Relapsed or Refractory Multiple Myeloma

Lilly Wilson, Adam D. Cohen, MD, Brendan M. Weiss, MD, Dan T. Vogl, MD, Alfred L. Garfall, MD, Donna L. Capozzi, PharmD, Patricia Mangan, MSN, CRNP, Mary Sanchez, MSN, CRNP, Colleen Erb, MSN, CRNP, Edward Stadtmauer, MD

Blood (2016) 128 (22): 2119.

https://doi.org/10.1182/blood.V128.22.2119.2119

Published: 2016

Journal Articles

Evaluation of Direct Oral Anticoagulants in the Treatment of Venous Thromboembolism for Inherited Thrombophilia Disorders

Ali McBride, PharmD,MS, Reem Diri, PharmD, Ravitharan Krishnadasan, MD, Pavani Chalasani, MD MPH, Ivo Abraham, PhD RN, Chris Campen, PharmD

Blood (2016) 128 (22): 5007.

https://doi.org/10.1182/blood.V128.22.5007.5007

Published: 2016

Journal Articles

Evaluation of Efficacy and Safety of Direct Oral Anticoagulants (DOACS) in the Treatment of Venous Thromboembolism in Cancer Patients

Ali McBride, PharmD,MS, Reem Diri, PharmD, Chris Campen, PharmD, Ivo Abraham, PhD RN

Blood (2016) 128 (22): 5016.

https://doi.org/10.1182/blood.V128.22.5016.5016

Published: 2016

Journal Articles

Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a "Proof of Concept" Phase II Study of the French LOC Network

Herve Ghesquieres, MD PhD, Caroline Houillier, MD, Olivier Chinot, MD PhD, Sylvain Choquet, MD, Cecile Molucon-Chabrot, MD, Patrick Beauchene, MD, Remy Gressin, MD, Franck Morschhauser, Anna Schmitt, MD, Emmanuel Gyan, MD PhD, Khê Hoang-Xuan, MD PhD, Emmanuelle Nicolas-Virelizier, MD, Marion Chevrier, Alexia Savignoni, MD, Isabelle Turbiez, Florence Veillas, Vassili Soumelis, MD PhD, Carole Soussain, MD PhD

Blood (2016) 128 (22): 785.

https://doi.org/10.1182/blood.V128.22.785.785

Published: 2016

Journal Articles

Massive Pulmonary and Coronary Artery Thromboembolism in the Setting of Undetected Patent Foramen Ovale

Sarah Thomas, MD, Diana Braswell, MD, Corinne Stephenson, MD

Blood (2015) 126 (23): 4718.

https://doi.org/10.1182/blood.V126.23.4718.4718

Published: 2015

Journal Articles

An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)

Christine I Chen, MD, Harminder Paul, Susi Snitzler, RN, Lisa W Le, MSc, Ellen Nong Wei, Anthea Lau, James B Johnston, MD, Spencer B. Gibson, PhD, Michelle L. Queau, B.Sc, Suzanne Trudel, MD

Blood (2015) 126 (23): 4163.

https://doi.org/10.1182/blood.V126.23.4163.4163

Published: 2015

Journal Articles

Overuse of DVT Prophylaxis in Medical Inpatients

Jing Deng, MD, Lisa Thomas, MD, Huijing Li, MD, Elvin Varughesekutty, MD, Qi Shi, MD, Meenakshi Sambharia, MD, Kevin Musto, MD, Gaurav Petal, MD, Erin Gordon, MD, Sudeep Ruparella, MD, Rajiv Bansal, MD

Blood (2015) 126 (23): 5563.

https://doi.org/10.1182/blood.V126.23.5563.5563

Published: 2015

Journal Articles

Pomalidomide Plus Low-Dose Dexamethasone (Pom/Dex) in Relapsed Lenalidomide Refractory Myeloma: Long Term Follow up and Comparison of 2 Mg Vs 4 Mg Doses

Blood (2014) 124 (21): 4780.

https://doi.org/10.1182/blood.V124.21.4780.4780

Published: 2014

Journal Articles

Validation Studies on Coagulation Laboratory Assays Useful for Assessing the Plasma Levels of Apixaban

Debra Hoppensteadt, PhD, Marc Goldford, PhD, Anne Bisset, PhD, Daneyal Syed, BS, Leon Zuckerman, PhD, Walter Jeske, PhD, Job Harenberg, MD, Jawed Fareed, PhD

Blood (2014) 124 (21): 2866.

https://doi.org/10.1182/blood.V124.21.2866.2866

Published: 2014

Journal Articles

Safety of Desirudin Administered in the Immediate Postoperative Period Following Joint Replacement Surgery: An Observational Study

Maurice Jove, MD, Marc Maslanka, James Meyer, PharmD

Blood (2014) 124 (21): 5085.

https://doi.org/10.1182/blood.V124.21.5085.5085

Published: 2014

NARROW

Sub-Cutaneous Rituximab-Minichop Versus Sub-Cutaneous Rituximab-Minichop + Lenalidomide (R2-miniCHOP) in Diffuse Large B Cell Lymphoma for Patients of 80 Years Old or More (SENIOR Study). a Multicentric Randomized Phase III Study of the Lysa

The Incidence of Heparin Induced Thrombocytopenia before and after the Implementation of the Venous Thromboembolism Thromboprophylaxis Protocols within Eastern Health

Prevalence of Venous Thromboembolism in Ambulatory and Non-Ambulatory Patients with Cerebral Palsy

Hypofibrinogenemia in Patient with Extended Exposure to Argatroban Therapy

Risk Factors and Outcomes of Deep Vein Thrombosis in Pediatric Osteomyelitis

Real World Outcomes with VTD and Cybord Induction Treatment for Transplant Eligible Multiple Myeloma Patients in a Latin American Country. Retrospective Cohort Study from Gamm (Grupo Argentino de Mieloma Multiple)

Comparative Use of Direct Oral Anticoagulants and Warfarin in the Treatment of Atrial Fibrillation and Venous Thromboembolism and Prophylaxis: A Retrospective Single Center Utilization Study

Incidence of Bleeding Events in Acute Myeloid Leukemia (AML) Patients Receiving Anticoagulation Therapy for Treatment of Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE) Who Are Also Undergoing Induction or Re-Induction Therapy

Response-Adapted Therapy for Newly Diagnosed Myeloma

Heparin-Induced Thrombocytopenia Antibody Testing and Its Cost Effectiveness: Taking a Financial HIT

Pembrolizumab in Combination with Pomalidomide and Dexamethasone (PEMBRO/POM/DEX) for Pomalidomide Exposed Relapsed or Refractory Multiple Myeloma

Evaluation of Direct Oral Anticoagulants in the Treatment of Venous Thromboembolism for Inherited Thrombophilia Disorders

Evaluation of Efficacy and Safety of Direct Oral Anticoagulants (DOACS) in the Treatment of Venous Thromboembolism in Cancer Patients

Rituximab-Lenalidomide (REVRI) in Relapse or Refractory Primary Central Nervous System (PCNSL) or Vitreo Retinal Lymphoma (PVRL): Results of a "Proof of Concept" Phase II Study of the French LOC Network

Massive Pulmonary and Coronary Artery Thromboembolism in the Setting of Undetected Patent Foramen Ovale

An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)

Overuse of DVT Prophylaxis in Medical Inpatients

Pomalidomide Plus Low-Dose Dexamethasone (Pom/Dex) in Relapsed Lenalidomide Refractory Myeloma: Long Term Follow up and Comparison of 2 Mg Vs 4 Mg Doses

Validation Studies on Coagulation Laboratory Assays Useful for Assessing the Plasma Levels of Apixaban

Safety of Desirudin Administered in the Immediate Postoperative Period Following Joint Replacement Surgery: An Observational Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only